Press Release October 12, 2021Agenus to Receive $20M Milestone Payment from Bristol Myers Squibb with Dosing of First Patient with its TIGIT Bispecific Antibody 0 0 Share
Press Release October 12, 20212 Stocks Set to Win From the Historic Malaria Vaccine Approval 0 0 Share
Company Ticker News September 17, 2021Agenus' Combo Therapy Trial Shows Higher Responses In Cervical Cancer 0 0 Share
Press Release September 16, 2021Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be Presented at ESMO 0 0 Share
Press Release August 26, 2021Balstilimab Monotherapy Data Published in Gynecologic Oncology 0 0 Share
Company Ticker News August 9, 2021Agenus' (AGEN) CEO Garo Armen on Q2 2021 Results - Earnings Call Transcript 0 0 Share
